Rhythm Pharmaceuticals (RYTM) Other Non Operating Income (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Other Non Operating Income of -$1.7 million for Q1 2026, down 164.6% year-over-year from $2.6 million in Q1 2025, and down 3089.47% quarter-over-quarter from $57000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Other Non Operating Income (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Other Non Operating Income for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 164.6% year-over-year to -$1.7 million; the TTM figure through Mar 2026 stood at $203000.0 (down 90.6% YoY), while the FY2025 annual figure was $1.3 million, down 43.55% from the prior year.
- Other Non Operating Income declined to -$1.7 million in Q1 2026 per RYTM's latest filing, from $57000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $8.4 million in Q2 2024 and bottomed at -$6.7 million in Q4 2024.
- Historically, Other Non Operating Income has averaged $111529.4 across 5 years, with a median of -$27000.0 in 2023.
- On a YoY basis, Other Non Operating Income climbed as much as 49370.59% in 2024 and fell as far as 1905.15% in 2024.
- Rhythm Pharmaceuticals' Other Non Operating Income stood at -$420000.0 in 2022, then surged by 187.86% to $369000.0 in 2023, then plunged by 1905.15% to -$6.7 million in 2024, then jumped by 100.86% to $57000.0 in 2025, then tumbled by 3089.47% to -$1.7 million in 2026.
- Business Quant data shows RYTM's Other Non Operating Income at -$1.7 million in Q1 2026, $57000.0 in Q4 2025, and $274000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | -644,000.00 |
| Dec 31, 2024 | -6.66 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 8.38 Mn |
| Mar 31, 2024 | 524,000.00 |
| Dec 31, 2023 | 369,000.00 |
| Sep 30, 2023 | -159,000.00 |
| Jun 30, 2023 | -17,000.00 |
| Mar 31, 2023 | -27,000.00 |
| Dec 31, 2022 | -420,000.00 |
| Sep 30, 2022 | -370,000.00 |
| Jun 30, 2022 | -133,000.00 |
| Mar 31, 2022 | -233,000.00 |
| Mar 31, 2021 | 100.00 Mn |